ArticleAddiction science & clinical practice2026
Treatment of alcohol use disorder via magnetic resonance-guided focused ultrasound ablation surgery.
Article in Addiction science & clinical practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlcohol use disorder (AUD) is a problematic pattern of drinking that can cause significant impairment or distress. Magnetic resonance-guided focused ultrasound (MRgFUS) is a novel noninvasive technique permitting incision-less ablative treatment, which may be effective for AUD. CASE PRESENTATION: We present the case of a 54-year-old man diagnosed with AUD for 30 years. After bilateral nucleus accumbens (NAc) MRgFUS, his craving for alcohol decreased markedly from 6 to 0, and he remained abstinent throughout the follow-up (12 months). Moreover, psychiatric and neuropsychological assessments showed improvements in depression, anxiety, sleep, and quality of life. Besides, he did not have any serious adverse effects during the whole follow-up period.
conclusionsThis case report suggests the feasibility and potential of NAc ablation via MRgFUS in treating severe AUD. Subsequent multi-sample double-blind controlled trials need to be further studied. The effect of MRgFUS on the use disorders of other substances also requires further research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.